← All Signals

🏥 FDA: ACME UNITED CORPORATION — Class II

healthcareneutralSource: FDA
80%Confidence
0Views
FDASource
2026-04-01Date

Summary

The WipesPlus recall extends Acme United's quality issues to another private label customer, indicating the problem affects multiple distribution channels. This could trigger broader market shifts away from Acme-manufactured antiseptic products.

Actionable: Monitor market share shifts in the antiseptic wipe segment and identify emerging alternative suppliers.

AI Confidence: 80%

Data Points

firmACME UNITED CORPORATION
classificationClass II
statusOngoing
distributionNationwide within the United States
productWipes Plus, Hand Sanitizing Alcohol Free BZK Wipes (Benzalkonium Chloride 0.13%), Manufactured for: CFS Brands DBA WipesPlus, 4711 E. Heiner Rd. Oklah

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now